P3 Health Partners Inc. Warrant

PIIIW
$0.01 -0.00 (-1.45%)
đźš« P3 Health Partners Inc. Warrant does not pay dividends

Company News

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
GlobeNewswire Inc. • N/A • June 3, 2025

Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims against P3 Health Partners, Inc. (PIII) for allegedly making false and misleading statements or omissions in violation of federal securities laws. The investigation is triggered by P3's disappointing financial results and a civil investigative demand from the Department of Justice.

Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
GlobeNewswire Inc. • N/A • February 10, 2025

Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of P3 Health Partners Inc. (PIII). Shareholders may be entitled to damages and corporate governance reforms.

P3 Health Partners to Participate at Upcoming Investor Conferences
GlobeNewswire Inc. • P3 Health Partners Inc. • March 7, 2022

HENDERSON, Nev., March 07, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners, Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company’s participation in the following investor conferences in March:

Related Companies